611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
What People With Type 1 Diabetes Need to Know About COVID-19Why Is COVID-19 Sometimes So Severe in Young Adults?Don't Count on Warmer Weather to Curb COVID-19FDA OKs Generic Asthma Inhaler in Face of Coronavirus-Related ShortagesNewborns With COVID-19 May Suffer Only Mild Symptoms, Study SaysAre Steroids Really the Answer for Arthritic Knees?Many Americans Will Grieve Parents, Grandparents Lost to CoronavirusTouching Your Face Is a Coronavirus Danger: Tips to Help You StopBlack Americans Appear Most Vulnerable as U.S. Coronavirus Deaths Near 13,000More COVID-19 Tests Arrive, But Bottlenecks PersistAHA News: What Pregnant Women With High Blood Pressure Need to Know About COVID-19AHA News: Pandemic Puts Health Care Workers' Mental Health on the LineU.S. Study Finds COVID-19 Seldom Severe in KidsHigh-Tech Rings Are Tracking COVID-19 'Warning Signs'Beware of 'Media Overload' During Coronavirus Crisis, Experts SayYou're Wearing a Face Mask -- Are You Wearing It Correctly?What Material Is Best for Your DIY Face Mask? The Answer May Surprise YouAs U.S. Coronavirus Death Toll Nears 11,000, Signs Show Pandemic May Be PeakingWhy Will It Take So Long for a COVID-19 Vaccine?Pregnant Women Need to Guard Against CoronavirusCollege Students Feeling the Strain of Social DistancingHow One Patient's Battle With COVID-19 Changed U.S. Testing ProtocolsMission Possible: Tips for Safe Grocery Shopping During the PandemicTrials Begin for Potential COVID-19 Drug RemdesivirSchool Closures Will Force Many U.S. Health Care Workers to Stay HomeWith Coronavirus a Threat, Stop Wearing Contact LensesSome Steroid Meds May Raise Coronavirus RiskAmericans Got the Memo on Social Distancing, Poll ShowsCDC Urges All Americans to Wear Face Masks as Death Count RisesAHA News: Amid Coronavirus Crisis, Exercise Caution When Exercising OutdoorsAsthma, COPD Raise Odds for Severe COVID-19, Lung Experts WarnCoronavirus Hangs Around Even After Symptoms SubsideCan Food From an Infected Cook Give You COVID-19?Pregnant Women Need to Guard Against CoronavirusVitamin D Might Aid Seniors' Recovery From Hip Fracture: StudyWith 3D Printer, N.Y. Hospital Converts Sleep Apnea Machines Into VentilatorsAnother COVID-19 Vaccine Being Tested in Mice'Stay at Home' Orders Are Stressing U.S. Families, Survey ShowsAn Expert's Guide to Fighting Coronavirus StressHeart Patients Need to Be Wary of CoronavirusU.S. Coronavirus Cases Pass 200,000, as Jobless Claims Soar to 10 MillionIs Thyroid Hormone Dangerously Overprescribed in Older Patients?'Pink Eye' Often a Symptom of COVID-19, and Infection Via Tears PossibleMild COVID-19 Often Appears With Only Gastro Symptoms: StudyFDA Pulls Heartburn Drug Zantac From MarketCertain Health Conditions Up Risks for Severe COVID-19Parents, Arm Your Kids Against COVID-19 With Good Hand-Washing HabitsFDA Approves Malaria Drugs to Treat COVID-19, Despite Little Proof They Work'Fever Tracker' Suggests Social Distancing Is Already WorkingDon't Fall Prey to COVID-19 Scammers
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

COVID-19 May Force Some Cancer Patients to Delay Treatment

HealthDay News
by By E.J. Mundell
HealthDay Reporter
Updated: Mar 25th 2020

new article illustration

WEDNESDAY, March 25, 2020 (HealthDay News) -- Early findings involving cancer patients from Wuhan, China -- the original epicenter of the COVID-19 pandemic -- suggest that many contracted the coronavirus while undergoing treatment in the hospital.

That could mean that this vulnerable population might need to discuss delaying cancer care to help minimize their odds of infection, the study authors said.

"We propose that aggressive measures be undertaken to reduce frequency of hospital visits of patients with cancer during a viral epidemic going forward," wrote a team led by Dr. Conghua Xie, of the department of radiation and medical oncology at Zhongnan Hospital of Wuhan University.

The research, which focused on 12 cancer patients treated at the hospital in January and February, was published March 25 in the journal JAMA Oncology.

It's long been understood that cancer, as well as its therapies, have the unfortunate side effect of weakening a patient's immune system. That can leave a patient more vulnerable to infectious illness, including COVID-19.

In the new study, Xie's team tracked infection incidence among more than 1,500 patients with cancer admitted to Zhongnan Hospital.

Twelve of those patients were later diagnosed with COVID-19, and the infection rate of the cancer patients was more than double that of the general population of Wuhan.

That's probably because people with cancer are often "immunocompromised," Xie's group wrote, and many may contract the new coronavirus during visits to the hospital for cancer care.

As seen in the general population, the risk of developing COVID-19 among cancer patients tended to rise with age: eight of 12 patients were over 60. Seven patients had lung cancer.

Three of the patients -- two with lung cancer, another with pancreatic cancer -- went on to develop severe COVID-19 requiring ICU care. All three died.

Of the remaining nine patients, six have recovered and have been discharged from the hospital, the team said.

According to the researchers, the take-home message from this small, early study is that during the COVID-19 pandemic, decisions may need to be made on curtailing cancer care. And if patients do require in-hospital treatment, "proper isolation protocols must be in place to mitigate the risk of [viral] infection," they said.

Three cancer specialists in the United States who reviewed the report agreed that cancer treatment may require patient-doctor discussions at this time.

Amy Moore directs science and research at the GO2 Foundation for Lung Cancer in Washington, D.C. She believes that lung cancer patients, especially, "may have elevated risk [of coronavirus infection] compared to other cancer types."

Also, Moore said, "hospital admissions and recurrent visits increase risk, reinforcing the importance of patients talking to their physicians regarding their own personal treatment plan."

Dr. Wasif Saif is medical director at the Northwell Health Cancer Institute in Lake Success, N.Y. He stressed that the study population was very small, so the findings must be considered preliminary. But certain patterns emerged.

"Cancer patients were deemed to be at highest risk for severe complications, including admission to the intensive care unit requiring invasive ventilation, or death," Saif noted. "Additionally, diagnosis of cancer was associated with a shorter time to development of severe events when compared to non-cancer patients."

Because hospitals are especially potent venues for coronavirus infection, Saif believes that "tough decisions have to be made during this COVID-19 crisis whether to delay [cancer] treatment or simplify the treatment."

But Dr. Adil Akhtar, director of inpatient clinical operations at Karmanos Cancer Institute at McLaren Oakland in Pontiac, Mich., took a slightly different view.

He agreed that cancer patients appear to be at higher odds of coronavirus infection, but added that "cancer programs across the U.S. have already implemented robust infection and environmental controls, as per the [U.S. Centers for Disease Control and Prevention] guidelines."

Akhtar added that, as per guidelines from the American Society of Clinical Oncology, at this time "there is no direct evidence to support changing or withholding chemotherapy or immunotherapy in patients with cancer."

He believes it's tough to determine, on an individual patient basis, whether the risk of contracting COVID-19 outweighs the benefit to be gained from continued cancer care.

So "clinical decisions should be individualized that consider factors such as the risk of cancer recurrence if therapy is delayed, modified or interrupted; the number of cycles of therapy already completed, and the patient's tolerance of treatment," Akhtar said.

More information

The U.S. Centers for Disease Control and Prevention has more on the new coronavirus.